What's in Mahmoud Ramadan mohamed Elkazzaz's pipeline?

Mahmoud Ramadan mohamed Elkazzaz has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Mahmoud Ramadan mohamed Elkazzaz's portfolio?

Top competitors by shared drug class: Groupe d'etude et de travail sur les leucemies aigues promyelocytaires, South China Children's Leukemia Group.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mahmoud-ramadan-mohamed-elkazzaz.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Mahmoud Ramadan mohamed Elkazzaz — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mahmoud Ramadan mohamed Elkazzaz pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
All trans-retinoic acid	All trans-retinoic acid	phase 3	Retinoid; differentiation agent	Retinoic acid receptor-alpha (RAR-alpha)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Groupe d'etude et de travail sur les leucemies aigues promyelocytaires · 1 shared drug class
South China Children's Leukemia Group · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mahmoud Ramadan mohamed Elkazzaz:

Cite this brief

Drug Landscape (2026). Mahmoud Ramadan mohamed Elkazzaz — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mahmoud-ramadan-mohamed-elkazzaz. Accessed 2026-05-16.